What the withdrawal study showed, how to plan coming off, and the habits that stay with you.
Find Your Body ProtocolWhen people stop Tirzepatide, appetite usually returns, and in a large withdrawal study many people regained a substantial share of the weight they had lost over the following year. That doesn’t mean you’re locked in forever, but it does mean the habits you build while on it (training, protein, sleep, portion control) are what you keep. Never stop or change your dose without talking to your physician, who can plan a step-down with you.
In the SURMOUNT-4 trial, everyone took Tirzepatide for several months first. Then some switched to a placebo without knowing it, while others kept taking Tirzepatide. The people who switched to placebo regained a substantial share of the weight they had lost over the following year, while those who stayed on it mostly held on to their loss. Other health markers that had improved also tended to drift back.
That study tested a sudden switch to placebo, not a planned step-down with support. It shows what the medication is doing while you take it: helping manage appetite.
Not necessarily. Some people stay on it long term with their physician’s guidance, others step down to a lower dose, and some come off. Which fits you is a decision you make with your physician based on your health, your goals and how you’re doing.
The ones you build while you’re on it. Use the time when appetite is quieter to lock in the routine:
Prescription required. A licensed physician decides whether compounded Tirzepatide is appropriate for you, and your dose.
Boxed warning: risk of thyroid C-cell tumors. In animal studies, Tirzepatide caused thyroid C-cell tumors. It is unknown whether it causes these tumors, including medullary thyroid carcinoma (MTC), in people. Do not use Tirzepatide if you or a family member have ever had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Possible serious side effects include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or a sulfonylurea), kidney problems from dehydration and serious allergic reactions.
The most common side effects are nausea, diarrhea, vomiting, constipation, stomach pain, indigestion and decreased appetite.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality. Compounded Tirzepatide is prepared by Strive Pharmacy, a state-licensed 503A compounding pharmacy. Not available in Arkansas, Indiana or South Carolina.
Two minutes of questions, then a short medical intake. A licensed physician decides whether compounded Tirzepatide is appropriate for you, and your dose. Not approved? Full refund.